Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Non-Current Assets (2016 - 2025)

Adma Biologics (ADMA) has disclosed Non-Current Assets for 14 consecutive years, with $157.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets changed 0.29% year-over-year to $157.7 million, compared with a TTM value of $641.3 million through Dec 2025, up 70.18%, and an annual FY2025 reading of $157.7 million, changed 0.29% over the prior year.
  • Non-Current Assets was $157.7 million for Q4 2025 at Adma Biologics, down from $166.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $166.0 million in Q3 2025 and bottomed at $58.4 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $93.4 million, with a median of $74.9 million recorded in 2023.
  • The sharpest move saw Non-Current Assets dropped 7.55% in 2023, then soared 129.25% in 2025.
  • Year by year, Non-Current Assets stood at $67.5 million in 2021, then increased by 15.6% to $78.1 million in 2022, then dropped by 7.55% to $72.2 million in 2023, then soared by 117.92% to $157.3 million in 2024, then rose by 0.29% to $157.7 million in 2025.
  • Business Quant data shows Non-Current Assets for ADMA at $157.7 million in Q4 2025, $166.0 million in Q3 2025, and $158.8 million in Q2 2025.